The current knowledge of definite resistance mechanisms include the modulation of other non-VEGF-related angiogenesis mechanisms, immunogenic pathways, tumor hypoxia, VEGF overexpression and vascular pericyte overpopulation [104,105]. The gene discussed is VEGFA; the disease is neoplasm.